Cargando…

Expression of tissue factor in non-small-cell lung cancers and its relationship to metastasis

Tissue factor (TF) is an initiator of the extrinsic cascade of blood coagulation. Although recent studies have revealed a relationship between metastatic properties and TF expression in some neoplastic cells, the significance of TF in lung cancer, especially in non-small-cell lung cancer (NSCLC), is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sawada, M, Miyake, S, Ohdama, S, Matsubara, O, Masuda, S, Yakumaru, K, Yoshizawa, Y
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1999
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362438/ https://www.ncbi.nlm.nih.gov/pubmed/10027315 http://dx.doi.org/10.1038/sj.bjc.6690073

Ejemplares similares

The expression of vascular endothelial growth factor C and its receptors in non-small cell lung cancer
por: Kajita, T, et al.
Publicado: (2001)

Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasis
por: Tsurusaki, T, et al.
Publicado: (1999)

Cyclin D1 expression in non-small-cell lung cancers: its association with altered p53 expression, cell proliferation and clinical outcome
por: Mishina, T, et al.
Publicado: (1999)

Phase I/II study of weekly irinotecan and concurrent radiation therapy for locally advanced non-small cell lung cancer
por: Takeda, K, et al.
Publicado: (1999)

Influence of angiogenetic factors and matrix metalloproteinases upon tumour progression in non-small-cell lung cancer
por: Shou, Y, et al.
Publicado: (2001)

Expression of vascular endothelial growth factor mRNA in non-small-cell lung carcinomas
por: Fontanini, G, et al.
Publicado: (1999)

Motility-related protein (MRP-1/CD9) and KAI1/CD82 expression inversely correlate with lymph node metastasis in oesophageal squamous cell carcinoma
por: Uchida, S, et al.
Publicado: (1999)

Prognostic value of performance status assessed by patients themselves, nurses, and oncologists in advanced non-small cell lung cancer
por: Ando, M, et al.
Publicado: (2001)

Apoptosis and p53 status predict the efficacy of postoperative administration of UFT in non-small cell lung cancer
por: Tanaka, F, et al.
Publicado: (2001)

Predictive value of expression of p16(INK4A), retinoblastoma and p53 proteins for the prognosis of non-small-cell lung cancers
por: Hommura, F, et al.
Publicado: (1999)

Fractionated administration of irinotecan and cisplatin for treatment of non-small-cell lung cancer: a phase II study of Okayama Lung Cancer Study Group
por: Ueoka, H, et al.
Publicado: (2001)

Phase II study of S-1, a novel oral fluorouracil, in advanced non-small-cell lung cancer
por: Kawahara, M, et al.
Publicado: (2001)

Loss of Fhit expression in non-small-cell lung cancer: correlation with molecular genetic abnormalities and clinicopathological features
por: Geradts, J, et al.
Publicado: (2000)

Cost-effectiveness of paclitaxel plus cisplatin in advanced non-small-cell lung cancer
por: Earle, C C, et al.
Publicado: (1999)

Gemcitabine plus vinorelbine in elderly or unfit patients with non-small cell lung cancer
por: Beretta, G D, et al.
Publicado: (2000)

Effects of lymphopenia on survival in proton therapy with chemotherapy for non-small cell lung cancer
por: Nakamura, Masatoshi, et al.
Publicado: (2023)

New human hepatocellular carcinoma (HCC) cell line with highly metastatic potential (MHCC97) and its expressions of the factors associated with metastasis
por: Tian, J, et al.
Publicado: (1999)

The bmi-1 oncoprotein is differentially expressed in non-small cell lung cancer and correlates with INK4A-ARF locus expression
por: Vonlanthen, S, et al.
Publicado: (2001)

Tissue factor expression in breast cancer tissues: its correlation with prognosis and plasma concentration
por: Ueno, T, et al.
Publicado: (2000)

Detection of large molecular weight cytokeratin 8 as carrier protein of CA19–9 in non-small-cell lung cancer cell lines
por: Fujita, J, et al.
Publicado: (1999)

Phase II study of gemcitabine and vindesine in patients with previously untreated non-resectable non-small-cell lung cancer
por: Sørensen, J B, et al.
Publicado: (1999)

p16 protein expression is associated with a poor prognosis in squamous cell carcinoma of the lung
por: Huang, C-I, et al.
Publicado: (2000)

Expression of apoptosis regulatory proteins of the Bcl-2 family and p53 in primary resected non-small-cell lung cancer
por: Borner, M M, et al.
Publicado: (1999)

Aneuploidy and prognosis of non-small-cell lung cancer: a meta-analysis of published data
por: Choma, D, et al.
Publicado: (2001)

Relevance of proliferative and pro-apoptotic factors in non-small-cell lung cancer for patient survival
por: Volm, M, et al.
Publicado: (2000)

Gefitinib versus Docetaxel in Treated Non-small-cell Lung Cancer: A Meta-analysis
por: Wang, Bing, et al.
Publicado: (2017)

Vesnarinone and glucocorticoids cooperatively induce G(1) arrest and have an anti-tumour effect on human non-small cell lung carcinoma cells grown in nude mice
por: Honma, Y, et al.
Publicado: (1999)

Mediastinal lymph node metastasis model by orthotopic intrapulmonary implantation of Lewis lung carcinoma cells in mice
por: Doki, Y, et al.
Publicado: (1999)

Combined paclitaxel and gemcitabine as first-line treatment in metastatic non-small cell lung cancer: a multicentre phase II study
por: Douillard, J Y, et al.
Publicado: (2001)

Mechanisms of synergism between cisplatin and gemcitabine in ovarian and non-small-cell lung cancer cell lines
por: Moorsel, C J A van, et al.
Publicado: (1999)

Molecular epidemiological study of non-small-cell lung cancer from an environmentally polluted region of Poland
por: Rusin, M, et al.
Publicado: (1999)

Cyclin D1 overexpression is an indicator of poor prognosis in resectable non-small cell lung cancer
por: Keum, J S, et al.
Publicado: (1999)

Therapy of human non-small-cell lung carcinoma using antibody targeting of a modified superantigen
por: Forsberg, G, et al.
Publicado: (2001)

Thrombospondin 2 expression is correlated with inhibition of angiogenesis and metastasis of colon cancer
por: Tokunaga, T, et al.
Publicado: (1999)

Phase II study of compensator-based non-coplanar intensity-modulated radiotherapy for Stage I non–small-cell lung cancer
por: Itonaga, Tomohiro, et al.
Publicado: (2019)

Expression of THOP1 and Its Relationship to Prognosis in Non-Small Cell Lung Cancer
por: Qi, Lei, et al.
Publicado: (2014)

Limited doses of immunotherapy use in advanced non‐small cell lung cancer elderly patients with ECOG of 2 and high PDL‐1 expression
por: Wong, Pui Yee, et al.
Publicado: (2021)

Concurrent conventionally factionated radiotherapy and weekly docetaxel in the treatment of stage IIIb non-small-cell lung carcinoma
por: Koukourakis, M I, et al.
Publicado: (1999)

Enhanced VEGF production and decreased immunogenicity induced by TGF-β 1 promote liver metastasis of pancreatic cancer
por: Teraoka, H, et al.
Publicado: (2001)

A phase II study of cisplatin and 5-fluorouracil with concurrent hyperfractionated thoracic radiation for locally advanced non-small-cell lung cancer: a preliminary report from the Okayama Lung Cancer Study Group
por: Segawa, Y, et al.
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_inaute8ig6t006930s05q20ca0